Jasna Klen

518 total citations
21 papers, 250 citations indexed

About

Jasna Klen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Jasna Klen has authored 21 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 5 papers in Physiology. Recurrent topics in Jasna Klen's work include Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (6 papers) and Diabetes Management and Research (5 papers). Jasna Klen is often cited by papers focused on Diabetes Treatment and Management (8 papers), Pancreatic function and diabetes (6 papers) and Diabetes Management and Research (5 papers). Jasna Klen collaborates with scholars based in Slovenia, United States and Croatia. Jasna Klen's co-authors include Vita Dolžan, Andrej Janež, Katja Goričar, Dubravka Jurišić‐Eržen, Nada Rotovnik Kozjek, Simon Horvat, Aleš Blinc, Tanja Blagus, Jure Stojan and Tanja Kunej and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Obesity Reviews.

In The Last Decade

Jasna Klen

20 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasna Klen Slovenia 10 131 103 80 23 23 21 250
Evangelia Tzeravini Greece 6 192 1.5× 94 0.9× 85 1.1× 28 1.2× 8 0.3× 14 299
Zhi Wei Jiang United States 5 225 1.7× 161 1.6× 101 1.3× 34 1.5× 15 0.7× 5 339
Lesley-Ann Huggins United States 7 146 1.1× 98 1.0× 80 1.0× 58 2.5× 7 0.3× 7 299
Olivier Scruel France 11 141 1.1× 82 0.8× 142 1.8× 38 1.7× 21 0.9× 20 311
Norimi Ohashi Japan 10 91 0.7× 82 0.8× 33 0.4× 45 2.0× 24 1.0× 13 288
Sanam Ebtehaj United States 6 94 0.7× 27 0.3× 69 0.9× 48 2.1× 32 1.4× 9 200
Zhongyuan Wen China 11 58 0.4× 104 1.0× 43 0.5× 52 2.3× 27 1.2× 20 299
Jaroslava Trnovská Czechia 9 53 0.4× 98 1.0× 29 0.4× 38 1.7× 19 0.8× 25 232
Athina Trakaki Austria 8 66 0.5× 53 0.5× 53 0.7× 49 2.1× 24 1.0× 9 239

Countries citing papers authored by Jasna Klen

Since Specialization
Citations

This map shows the geographic impact of Jasna Klen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasna Klen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasna Klen more than expected).

Fields of papers citing papers by Jasna Klen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasna Klen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasna Klen. The network helps show where Jasna Klen may publish in the future.

Co-authorship network of co-authors of Jasna Klen

This figure shows the co-authorship network connecting the top 25 collaborators of Jasna Klen. A scholar is included among the top collaborators of Jasna Klen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasna Klen. Jasna Klen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jurišić‐Eržen, Dubravka, et al.. (2025). The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies. Obesity Reviews. 26(12). e13978–e13978. 1 indexed citations
2.
Janež, Andrej, et al.. (2025). Erectile Dysfunction in Diabetes Mellitus: A Comprehensive Narrative Review of Pathophysiology, Genetic Association Studies and Therapeutic Approaches. Endocrinology Diabetes & Metabolism. 8(5). e70099–e70099. 1 indexed citations
5.
Jurišić‐Eržen, Dubravka, et al.. (2024). Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. International Journal of Molecular Sciences. 25(3). 1517–1517. 20 indexed citations
7.
Klen, Jasna, et al.. (2023). Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice. International Journal of Molecular Sciences. 24(6). 5446–5446. 13 indexed citations
8.
Klen, Jasna & Vita Dolžan. (2023). SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation. Pharmaceutics. 15(7). 1995–1995. 15 indexed citations
9.
Klen, Jasna, Katja Goričar, & Vita Dolžan. (2023). The associations of PON1 and APOE polymorphisms with plasma lipid levels and the risk for late complications in type 2 diabetes patients. Journal of Medical Biochemistry. 42(4). 675–684.
10.
Klen, Jasna & Vita Dolžan. (2022). Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors. International Journal of Molecular Sciences. 23(7). 3451–3451. 34 indexed citations
12.
Klen, Jasna, et al.. (2021). Acquired haemophilia in patients with malignant disease: A case report. World Journal of Clinical Cases. 9(10). 2409–2418. 1 indexed citations
13.
Klen, Jasna, et al.. (2021). Multidisciplinary diagnostic and therapeutic approach to acute mesenteric ischaemia: A case report with literature review. SHILAP Revista de lepidopterología. 9. 2050313X211004804–2050313X211004804. 2 indexed citations
14.
Klen, Jasna & Vita Dolžan. (2021). Treatment Response to SGLT2 Inhibitors: From Clinical Characteristics to Genetic Variations. International Journal of Molecular Sciences. 22(18). 9800–9800. 22 indexed citations
15.
Klen, Jasna, Katja Goričar, & Vita Dolžan. (2019). Genetic variability in sodium-glucose cotransporter 2 influences glycemic control and risk for diabetic retinopathy in type 2 diabetes patients. Journal of Medical Biochemistry. 0(0). 276–282. 11 indexed citations
16.
Klen, Jasna, Katja Goričar, Simon Horvat, Jure Stojan, & Vita Dolžan. (2019). DEPTOR Polymorphisms Influence Late Complications in Type 2 Diabetes Patients. Pharmacogenomics. 20(12). 879–890. 2 indexed citations
17.
Klen, Jasna, Katja Goričar, Andrej Janež, & Vita Dolžan. (2015). NLRP3Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients. Journal of Diabetes Research. 2015. 1–6. 42 indexed citations
18.
Klen, Jasna, Katja Goričar, Andrej Janež, & Vita Dolžan. (2015). Common Polymorphisms in Antioxidant Genes are Associated with Diabetic Nephropathy in Type 2 Diabetes Patients. Personalized Medicine. 12(3). 187–198. 13 indexed citations
19.
Klen, Jasna, Vita Dolžan, & Andrej Janež. (2014). CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients. European Journal of Clinical Pharmacology. 70(4). 421–428. 47 indexed citations
20.
Klen, Jasna, Katja Goričar, Andrej Janež, & Vita Dolžan. (2014). The Role of Genetic Factors and Kidney and Liver Function in Glycemic Control in Type 2 Diabetes Patients on Long-Term Metformin and Sulphonylurea Cotreatment. BioMed Research International. 2014. 1–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026